An Observational Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia.

Trial Profile

An Observational Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Jun 2014

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms RELIVE
  • Sponsors Abbott Laboratories; AbbVie
  • Most Recent Events

    • 10 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Mar 2013 Planned end date changed from 1 May 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov
    • 19 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top